Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

This study is testing a new medication called aleniglipron to see if it can help control blood sugar in people with type 2 diabetes. Researchers want to find out how well it works and whether it is safe. **You may be eligible if...** - You have been diagnosed with type 2 diabetes for at least 6 months - Your HbA1c (a blood sugar average test) is between 6.5% and 10% - Your body mass index (BMI) is 27 or higher **You may NOT be eligible if...** - You are currently being treated for diabetic eye disease (retinopathy or macular edema) - You take medications that interfere with blood sugar levels - Your weight has changed by more than 11 pounds in the last 3 months - You have had or are planning weight-loss surgery - You have had a stomach or intestinal procedure for obesity in the last 6 months Talk to your doctor to see if this trial is right for you.